We are currently investigating Tasigna side effects cases as possible Tasigna drug injury lawsuits against Novartis for patients who have developed some serious medical conditions during their use of Tasigna. In early June 2021, the New Jersey Supreme Court consolidated Tasigna drug injury … More
Main Navigation Menu
➤ Current Drug Injury Lawsuits / Pharmaceutical Litigations
➤ Case Evaluations — Free. Confidential. No Obligation.
➤ Information About Law Offices of Thomas J. Lamb
➤ Questions New Clients Have Asked Us (FAQs)
➤ Patient Resources: Medical Sites and More
➤ Collection of Our “Side Effects” Blog Articles
Please know that you can use our Quick Contact Form to tell us about your case.
Recent News & Case Reports
Novartis Stops 3 Beovu Clinical Trials in May 2021, Wants a Beovu Label Change
In late May 2021, the latest study data concerning Beovu safety issues resulted in Novartis stopping three key clinical trials -- MERLIN, RAPTOR, and RAVEN -- as well as Novartis indicating there will be another Beovu label change. To see how Novartis is seeking to present the current status of … More
Ocaliva-related Liver Injury Warnings Will be Added to Ocaliva Drug Label
We now know more about the Ocaliva-related liver injury "safety signal" that the FDA has been investigating over the past year, and as a result of that Ocaliva FDA safety evaluation there will be an Ocaliva label change with new warnings. On May 26, 2021, this FDA Drug Safety Communication about … More
A 2021 Look at the Increased Risk of Elmiron-associated Pigmentary Maculopathy
We have reported previously on Elmiron-related eye damage, particularly that long-term use of the interstitial cystitis treatment drug Elmiron has been linked to maculopathy eye damage. In this post, we present a 2021 Elmiron medical journal article wherein it is estimated that around 20% of … More
Guidelines for Diagnosing and Managing Patients with Drug-induced Liver Injury
We continue to monitor the medical literature for developments relevant to the important drug safety issue of drug-induced liver injury (DILI). This medical journal article, "ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury", appeared in The American … More
Ocrevus PML Case Report: Patient Used Ocrevus, Only, Without Prior Tysabri or Gilenya Use
The primary source for this Ocrevus PML case report is a JAMA Neurology Brief Report item dated March 16, 2021, "Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy". From the Abstract for that medical journal article we … More